CN106070983A - Sod花旗参糖 - Google Patents
Sod花旗参糖 Download PDFInfo
- Publication number
- CN106070983A CN106070983A CN201610453456.2A CN201610453456A CN106070983A CN 106070983 A CN106070983 A CN 106070983A CN 201610453456 A CN201610453456 A CN 201610453456A CN 106070983 A CN106070983 A CN 106070983A
- Authority
- CN
- China
- Prior art keywords
- sugar
- panacis quinquefolii
- radix panacis
- sod
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- 239000000811 xylitol Substances 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 21
- 229960002675 xylitol Drugs 0.000 claims abstract description 21
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 claims abstract description 4
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000003908 liver function Effects 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 230000003907 kidney function Effects 0.000 abstract description 4
- 230000009102 absorption Effects 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000000474 nursing effect Effects 0.000 abstract description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 230000033228 biological regulation Effects 0.000 description 13
- 241000190633 Cordyceps Species 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 2
- 229940094720 viagra Drugs 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010044038 Tooth erosion Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000036595 non-bacterial tooth erosion Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于饮品养生领域，尤其涉及SOD花旗参糖。本发明所要解决的技术问题是提供一种可抗疲劳的SOD花旗参糖，由下列重量配比的组分组成：超氧化物歧化酶SOD1份、西洋参100份、木糖醇600份。本发明的有益效果：1、保健食品、纯植物精华、无依赖性、无副作用；2、含服效果好；3、抗疲劳、增强肝肾功能、改善夫妻生活、平衡血糖，增强肠胃吸收、护肤养颜延缓衰老、提高人体免疫力、抑制肿瘤细胞。
Description
技术领域
本发明属于养生保健技术领域，尤其涉及SOD花旗参糖。
背景技术
由于生活水平的不断提高，特别是饮食结构和生活方式的改变，人们的身体存在不同程度的亚健康，因此人们就会用到一些保健品，比如万艾可之类的，但是万艾可采用的是西药制剂，有严重副作用，还有严重的依赖性。
发明内容
本发明所要解决的技术问题是提供一种可抗疲劳的SOD花旗参糖。
本发明解决上述技术问题所采用的技术方案是：SOD花旗参糖，由下列重量配比的组分组成：超氧化物歧化酶SOD1份、西洋参100份、木糖醇600份。
进一步的是，所述木糖醇为无糖分木糖醇。
权利要求1至2的SOD花旗参糖的制备方法，包括以下步骤：首先按配比混合搅拌均匀，再用沸水预热法将其加热、溶解、搅拌均匀、成型，最后冷却、封装即可。
本发明的有益效果：1、保健食品、纯植物精华、无依赖性、无副作用；2、含服效果好；3、抗疲劳、增强肝肾功能、改善夫妻生活、平衡血糖，增强肠胃吸收、护肤养颜延缓衰老、提高人体免疫力、抑制肿瘤细胞。
具体实施方式
下面结合实施例对发明做进一步详细的说明。
本发明的SOD花旗参糖，由下列重量配比的组分组成：超氧化物歧化酶SOD1份、西洋参100份、木糖醇600份。所述木糖醇为无糖分木糖醇，西洋参为美国花旗参。
其中本技术采用纯植物精华虫草提取物超氧化物歧化酶SOD、美国花旗参、无糖分木糖醇制作而成。SOD超氧化物歧化酶能，是一种源于生命体的活性物质和抗衰老酶，本质是蛋白质。SOD广泛存在动植物体内，保护细胞不受自由基侵害。SOD通过血液循环清除体内自由基,当SOD与自由基相遇时，促使自由基分解为对人体无害的水分子和氧分子。SOD生理功能：提高人体免疫、抗癌、抗氧化缓衰老；平衡血糖；对糖尿病有明显恢复作用；强肝肾；防治前列腺炎；护肤养颜等功效。
SOD特点：1、生物发酵提取：无血液病毒及交叉感染危险；2、耐热性强：90℃环境120分钟酶活性几乎没有损失，100℃环境60分钟酶活性保持90％以上；3、稳定性高：在PH4.0-11.0范围内酶活性稳定，常温下保存两年酶活性维持在95％以上；4、分子量小：易被吸收；5、生物利用度高：利用率可达到95％以上。
虫草的功效：1)、调节免疫系统功能免疫系统，对内抵御肿瘤，清除老化、坏死的细胞组织，对外抗击病毒、细菌等微生物感染。它既能增加免疫系统细胞、组织数量，促进抗体产生，增加吞噬、杀伤细胞数量、增强其功能，又可以调低某些免疫细胞的功能。2)、直接抗肿瘤作用冬虫夏草提取物在体外具有明确的抑制、杀伤肿瘤细胞的作用。冬虫夏草中含有虫草素，是其发挥抗肿瘤作用的主要成分。3)、提高细胞能量、抗疲劳冬虫夏草能提高人体能量工厂--线粒体的能量，提高机体耐寒能力，减轻疲劳。4)、调节心脏功能冬虫夏草可提高心脏耐缺氧能力，降低心脏对氧的消耗，抗心律失常。5)、调节肝脏功能冬虫夏草可减轻有毒物质对肝脏的损伤。此外，通过调节免疫功能，增强抗病毒能力，对病毒性肝炎发挥有利作用。6)、调节呼吸系统功能冬虫夏草具有扩张支气管、平喘、祛痰、防止肺气肿的作用。7)、调节肾脏功能冬虫夏草能减轻慢性病的肾脏病变，改善肾功能，减轻毒性物质对肾脏的损害。8)、调节造血功能冬虫夏草能增强骨髓生成血小板、红细胞和白细胞的能力。9)、调节血脂冬虫夏草可以降低血液中的胆固醇和甘油三酯，提高对人体有利的高密度脂蛋白，减轻动脉粥样硬化。10)、其他冬虫夏草还具有直接抗病毒、调节中枢神经系统功能、调节性功能等作用。
花旗参的功效：1)对代谢的调节作用：在应激和强烈运动条件下，具有明显的抑制内源性糖元的作用，促进人体节约利用碳水化合物，因此花旗参能抗疲劳。2)增强免疫功能：能增强免疫功能包括促进抗体、补体形成和刺激非特异性免疫功能的作用。3)调节内分泌系统的功能：具有调节垂体—肾上腺皮质激素、性激素和甲状腺的功能。4)调节神经系统作用：增强学习和工作能力及抗疲劳作用，而且花旗参与其它中药配合可治疗心血管、泌尿系统等疾病。花旗参中的人参皂质，对离体的癌细胞有抑制的作用，同时长期使用，又无副作用。
木糖醇的功能：1)甜味剂木糖醇做糖尿病人的甜味剂、营养补充剂和辅助治疗剂：木糖醇是人体糖类代谢的中间体，在体内缺少胰岛素影响糖代谢情况下，无须胰岛素促进，木糖醇也能透过细胞膜，被组织吸收利用，促进肝糖元合成，供细胞以营养和能量，且不会引起血糖值升高，消除糖尿病人服用后的三多症状(多食、多饮、多尿)，是最适合糖尿病患者食用的营养性的食糖代替品。2)改善肝功能木糖醇能促进肝糖元合成，血糖不会上升，对肝病患者有改善肝功能和抗脂肪肝的作用，治疗乙型迁延性肝炎，乙型慢性肝炎及肝硬化有明显疗效，是肝炎并发症病人的理想辅助药物。3)防龋齿功能木糖醇的防龋齿特性在所有的甜味剂中效果最好，首先是木糖醇不能被口腔中产生龋齿的细菌发酵利用，抑制链球菌生长及酸的产生；其次在咀嚼木糖醇时，能促进唾液分泌，唾液多了既可以冲洗口腔、牙齿中的细菌，也可以增大唾液和龋齿斑点处碱性氨基酸及氨浓度，同时减缓口腔内PH值下降，伤害牙齿的酸性物质被中和稀释，抑制了细菌在牙齿表面的吸附，从而减少了牙齿的酸蚀，防止龋齿和减少牙斑的产生，巩固牙齿。4)减肥功能木糖醇为人体提供能量，合成糖元，减少脂肪和肝组织中的蛋白质的消耗，使肝脏受到保护和修复，减少人体内有害酮体的产生，不会因食用而为发胖忧虑。
实施例
将1克的超氧化物歧化酶SOD、100克的美国花旗参100份、600克无糖木糖醇混合搅拌均匀，再用沸水预热法将其加热、溶解、搅拌均匀、成型，最后冷却、封装。
Claims (3)
1.SOD花旗参糖，其特征在于，由下列重量配比的组分组成：超氧化物歧化酶SOD1份、西洋参100份、木糖醇600份。
2.根据权利要求1所述的SOD花旗参糖，其特征在于，所述木糖醇为无糖分木糖醇。
3.权利要求1至2的SOD花旗参糖的制备方法，其特征在于，包括以下步骤：首先按配比混合搅拌均匀，再用沸水预热法将其加热、溶解、搅拌均匀、成型，最后冷却、封装即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610453456.2A CN106070983A (zh) | 2016-06-22 | 2016-06-22 | Sod花旗参糖 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610453456.2A CN106070983A (zh) | 2016-06-22 | 2016-06-22 | Sod花旗参糖 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106070983A true CN106070983A (zh) | 2016-11-09 |
Family
ID=57238703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610453456.2A Pending CN106070983A (zh) | 2016-06-22 | 2016-06-22 | Sod花旗参糖 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106070983A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110876419A (zh) * | 2019-08-28 | 2020-03-13 | 李金荣 | 含有sod的木糖醇糖果、木糖醇糖果在肾保健领域中的应用及木糖醇糖果包装结构 |
| CN114271490A (zh) * | 2021-12-02 | 2022-04-05 | 深圳中科欣扬生物科技有限公司 | 一种含sod和麦角硫因的抗疲劳抗氧化和解酒功能的保健配方 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115605A (zh) * | 1994-09-23 | 1996-01-31 | 宫坚 | 抗衰老美容保健奶糖及制作方法 |
| US20080014331A1 (en) * | 2006-07-17 | 2008-01-17 | Constantin Badalov | Super sweet sugar crystals and syrups for health and method |
| CN101455261A (zh) * | 2009-01-07 | 2009-06-17 | 贺小茹 | 一种灵芝孢子粉花旗参糖及其生产方法 |
| CN102302077A (zh) * | 2011-08-26 | 2012-01-04 | 吉林紫鑫药业股份有限公司 | 人参糖及其生产工艺 |
| CN102406679A (zh) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | 一种中药西洋参口含片 |
| CN104336282A (zh) * | 2013-08-06 | 2015-02-11 | 庞树林 | 人参糖果 |
-
2016
- 2016-06-22 CN CN201610453456.2A patent/CN106070983A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115605A (zh) * | 1994-09-23 | 1996-01-31 | 宫坚 | 抗衰老美容保健奶糖及制作方法 |
| US20080014331A1 (en) * | 2006-07-17 | 2008-01-17 | Constantin Badalov | Super sweet sugar crystals and syrups for health and method |
| CN101455261A (zh) * | 2009-01-07 | 2009-06-17 | 贺小茹 | 一种灵芝孢子粉花旗参糖及其生产方法 |
| CN102302077A (zh) * | 2011-08-26 | 2012-01-04 | 吉林紫鑫药业股份有限公司 | 人参糖及其生产工艺 |
| CN102406679A (zh) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | 一种中药西洋参口含片 |
| CN104336282A (zh) * | 2013-08-06 | 2015-02-11 | 庞树林 | 人参糖果 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110876419A (zh) * | 2019-08-28 | 2020-03-13 | 李金荣 | 含有sod的木糖醇糖果、木糖醇糖果在肾保健领域中的应用及木糖醇糖果包装结构 |
| CN114271490A (zh) * | 2021-12-02 | 2022-04-05 | 深圳中科欣扬生物科技有限公司 | 一种含sod和麦角硫因的抗疲劳抗氧化和解酒功能的保健配方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| CN104223107B (zh) | 一种护肝解酒排毒的保健品 | |
| CN1927383B (zh) | 迅速降低氧化应激的复方制剂及其制备方法 | |
| CN100339023C (zh) | 一种胚蛋保健食品及其制造方法 | |
| CN105200105A (zh) | 一种牡蛎蛋白的保肝护肝肽制剂的制备方法 | |
| CN113632851A (zh) | 一种多功能儿童生长奶粉及其制备方法 | |
| KR101139372B1 (ko) | 한약재 미세캡슐을 이용한 증체목적용 돼지 사료첨가제 및 그 제조방법 | |
| CN104757560A (zh) | 一种谷胱甘肽酵母酶解组合物及其制备方法 | |
| CN105918387A (zh) | 一种适用中老年保健食品及制备方法 | |
| CN103976202B (zh) | 一种可食用胶原蛋白果冻及其制备方法 | |
| CN110313619A (zh) | 一种具有保肝护肝功效的复方肽及其制备方法 | |
| CN106070983A (zh) | Sod花旗参糖 | |
| CN106174286A (zh) | 高级金枸杞营养果酱 | |
| CN1738633A (zh) | 来自药用植物的抗肥胖组分及其组合物 | |
| CN105851805A (zh) | 一种保健杂粮粥及其制备方法 | |
| KR101218620B1 (ko) | 한약재와 아카시아꿀을 이용한 건강보조식품 | |
| CN1958035A (zh) | 用于降低血糖血脂和治疗糖尿病的药物组合物 | |
| CN106490268A (zh) | 一种用于解酒毒的茶饮及其制备方法 | |
| CN106901382A (zh) | 一种治疗孕妇感冒的保健制剂 | |
| KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
| CN101331948A (zh) | 一种含辅酶q10和螺旋藻的复合保健品 | |
| CN105495584A (zh) | 一种增强机体免疫力的以花生蛋白为主的食品生产方法 | |
| CN107801830A (zh) | 不含胶基可食用的牙齿口腔清洁片 | |
| CN108096281A (zh) | 一种健血强身组合物 | |
| KR101798180B1 (ko) | 마늘을 이용한 건강보조식품 및 그의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170919 Address after: Baoan District, Guangdong province Shenzhen Xixiang Street Huang Tian community Kai Cheng Road two residential building 201 Applicant after: SHENZHEN WANGBOTONG TECHNOLOGY CO., LTD. Address before: 518000, Shenzhen, Guangdong province Baoan District Xixiang Street Huang Tian community Kai Cheng Road two residential building 201 Applicant before: Shenzhen onebar Biological Engineering Co. Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
| RJ01 | Rejection of invention patent application after publication |